Ambrosia Bio
PrivateLast Round
Series A
Dec 10, 2024
Est. Valuation
$39.75M
Total Funding Raised
$25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ambrosia Bio operates in Healthcare & Life Sciences and is based in Jerusalem. Its latest recorded funding round was a Series A round in December 2024.
Ambrosia Bio is a biotechnology company that offers an enzyme-based technology for producing allulose, a low-calorie sugar substitute.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ambrosia Bio Comparables
Compare Ambrosia Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bonumose, Inc. | 81% | |
| Prodalim | 70% | |
| Amai Proteins | 68% |
For institutional investors. Book with your work email.
Ambrosia Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ambrosia Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BVF Partners L.P. | Series A |
| Boulder Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 75% MoM, from 733 to 1.3K.
- Jun 18, 2026
Monthly visitors increased 50% MoM.
For institutional investors. Book with your work email.
Ambrosia Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ambrosia Bio's valuation, stock price, and market status.
Is Ambrosia Bio a public or private company?
Ambrosia Bio is a private company.
What is the current stock price of Ambrosia Bio?
Ambrosia Bio is a private company, so its shares have no public market price. Caplight tracks Ambrosia Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ambrosia Bio worth (valuation)?
Ambrosia Bio's valuation is estimated at $39.8M based on funding round data.
Can I buy Ambrosia Bio stock?
Ambrosia Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ambrosia Bio's last funding round?
Ambrosia Bio's most recent funding round was Series A on December 10, 2024.
Who are the main investors in Ambrosia Bio?
Key investors in Ambrosia Bio include BVF Partners L.P., Boulder Ventures.
Will Ambrosia Bio IPO soon?
No public IPO plans have been announced for Ambrosia Bio.
How can I track Ambrosia Bio secondary market activity?
Caplight tracks bids, offers, and trades in Ambrosia Bio's shares on secondary markets.